Madhavan Balachandran - 04 Sep 2024 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Reporting relationship: Director
Issuer ticker: REPL
Reported as of: 04 Sep 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Sep 2024, 20:10:13 UTC
Prior SEC filing: 21 Jun 2024
Next SEC filing: 03 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Shawn Glidden, attorney-in-fact

Key filing fact

Madhavan Balachandran filed Form 4 for Replimune Group, Inc. (REPL) on 05 Sep 2024.

Key facts

This page summarizes Madhavan Balachandran's Form 4 filing for Replimune Group, Inc. (REPL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Sep 2024, 20:10.

Change

Previous filing in this sequence was filed on 21 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

REPL transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +64,000
Change %
Price: $0.000000
Shares after: 64,000
Date: 04 Sep 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 64,000
Exercise price: $10.44
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares underlying this stock option vest on September 4, 2025, and the remainder of the shares underlying this stock option vest in 24 approximately equal monthly installments thereafter.